Search Results - Qunying Mao

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody by Yiping Wang, Fan Gao, Zhenglun Liang, Huimin Sun, Junzhi Wang, Qunying Mao

Connect to this object online.

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays by Xuanxuan Zhang, Xing Wu, Qian He, Junzhi Wang, Qunying Mao, Zhenglun Liang, Miao Xu

Connect to this object online.

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern by Lianlian Bian, Jianyang Liu, Fan Gao, Qiushuang Gao, Qian He, Qunying Mao, Xing Wu, Miao Xu, Zhenglun Liang

Connect to this object online.

Research progress on the quality control of mRNA vaccines by Chaoying Hu, Yu Bai, Jianyang Liu, Yiping Wang, Qian He, Xuanxuan Zhang, Feiran Cheng, Miao Xu, Qunying Mao, Zhenglun Liang

Connect to this object online.

Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines by Xuanxuan Zhang, Jialu Zhang, Si Chen, Qian He, Yu Bai, Jianyang Liu, Zhongfang Wang, Zhenglun Liang, Ling Chen, Qunying Mao, Miao Xu

Connect to this object online.

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies by Yao Su, Pan Chen, Fan Gao, Lianlian Bian, Shiyang Sun, Fangyu Dong, Yalin Hu, Qunying Mao, Wei Jiang, Xing Wu, Zhenglun Liang

Connect to this object online.

Effect of freezing on recombinant hepatitis E vaccine by Kelei Li, Fangyu Dong, Fan Gao, Lianlian Bian, Shiyang Sun, Ruixiao Du, Yalin Hu, Qunying Mao, Haifa Zheng, Xing Wu, Zhenglun Liang

Connect to this object online.

Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China by Fan Gao, Lianlian Bian, Xiaotian Hao, Yalin Hu, Xin Yao, Shiyang Sun, Pan Chen, Ce Yang, Ruixiao Du, Jingxin Li, Fengcai Zhu, Qunying Mao, Zhenglun Liang

Connect to this object online.

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge by Ruixiao Du, Qunying Mao, Yalin Hu, Shuhui Lang, Shiyang Sun, Kelei Li, Fan Gao, Lianlian Bian, Ce Yang, Bopei Cui, Longfa Xu, Tong Cheng, Zhenglun Liang

Connect to this object online.

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris by Zhijian Yang, Fan Gao, Xiaoliang Wang, Likang Shi, Zheng Zhou, Yuanxiang Jiang, Xinxing Ma, Chao Zhang, Chenliang Zhou, Xianfang Zeng, Ge Liu, Jiang Fan, Qunying Mao, Li Shi

Connect to this object online.

Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial by Yan Li, Fan Gao, Yamin Wang, Jing Li, Yuxi Zhang, Huakun Lv, Shenyu Wang, Haitao Yang, Xiaoqiang Liu, Keli Li, Huaqing Wang, Zundong Yin, Zhenglun Liang, Zhijie An, Qunying Mao, Zijian Feng

Connect to this object online.

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains by Yaqian Huo, Jinghuan Yang, Pei Liu, Bopei Cui, Chenfei Wang, Siyuan Liu, Fangyu Dong, Xujia Yan, Lianlian Bian, Fan Gao, Xing Wu, Jiuyue Zhou, Tong Cheng, Xiuling Li, Qunying Mao, Zhenglun Liang

Connect to this object online.

A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine by Bopei Cui, Fang Cai, Fan Gao, Lianlian Bian, Ruixia Wu, Ruixiao Du, Xing Wu, Pei Liu, Lifang Song, Lisha Cui, Yadi Yuan, Siyuan Liu, Xiangzhong Ye, Tong Cheng, Qunying Mao, Qiang Gao, Zhenglun Liang

Connect to this object online.

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial by Jinhua Chen, Pengfei Jin, Xiaoqi Chen, Qunying Mao, Fanyue Meng, Xinguo Li, Wei Chen, Meizhi Du, Fan Gao, Pei Liu, Xiujuan Li, Changfu Guo, Tingbo Xie, Weiwei Lu, Qingliang Li, Li Li, Xing Yan, Xiang Guo, Hongqiao Du, Xiuling Li, Kai Duan, Fengcai Zhu

Connect to this object online.